{"SPADE_N_03151": {"Clinical Information": [], "Patent Information": [{"Patent No": "US 2008/0269122 A1", "Patent Link": "http://www.lens.org/lens/patent/US_2008_0269122_A1", "Patent Type": "Patent Application", "Publication Date": "2008-10-30", "Family Info": "CA2525961A1,WO2004110143A2,AU2004247012A1,US20050014932A1,WO2004110143A3", "Patent Title": "Antimicrobial Peptides Derived From Cap18.", "Abstract": "The present invention relates to retroviral constructs that encode novel monoclonal antibodies, novel fusion proteins, and chimeric monoclonal antibodies and to methods of using and producing the same. In particular, the present invention relates to methods of producing a fusion protein comprising a microorganism targeting molecule (e.g., immunoglobulin or innate immune system receptor molecule) and a biocide (e.g., bactericidal enzymes) in transgenic animals (e.g., bovines) and in cell cultures. The present invention also relates to therapeutic and prophylactic methods of using a fusion protein comprising a microorganism targeting molecule and a biocide in health care (e.g., human and veterinary), agriculture (e.g., animal and plant production), and food processing (e.g., beef carcass processing). The present invention also relates to methods of using a fusion protein comprising a microorganism targeting molecule and a biocide in various diagnostic applications in number of diverse fields such as"}], "Sequence Information": {"SPADE ID": "SPADE_N_03151", "Peptide Name": "Neutrophil defensin 4 (Defensin, alpha 4; HNP-4, HP-4; Human, mammals, animals)", "Source": "Homo sapiens (Human)", "Family": "Belongs to the alpha-defensin family", "Gene": "DEFA4", "Sequence": "VCSCRLVFCRRTELRVGNCLIGGVSFTYCCTRV", "Sequence Length": 33, "UniProt Entry": ["http://www.uniprot.org/uniprot/P12838"], "Protein Existence": "Protein level", "Biological Activity": ["Antimicrobial", "Antibacterial", "Anti-Gram+", "Anti-Gram-", "Antifungal", "Antiviral(SARS-CoV-2)"], "Target Organism": "[Ref.34206990]Virus:showed inhibition against SARS-CoV-2.Gram-negative bacteria:Escherichia coli ATCC 8739 (vLD50=3.3±0.4 µg/ml), E. coli ATCC 25922 (vLD50=3.0±0.7 µg/ml), Enterobacter aerogenes ATCC 13048 (vLD50=6.6±0.2 µg/ml);Gram-positive bacteria:Staphylococcus aureus ATCC 25923 (vLD50=7.3±1.4 µg/ml), S. aureus ATCC 29213 (vLD50=7.2±0.2 µg/ml), Bacillus cereus ATCC 10876 (vLD50=0.87±0.08 µg/ml).(Ref.4)NOTE:vLD50, virtual lethal doses (vLDs), equivalent to conventional 50% lethal doses (LD50s).Yeast:Candida albicans ATCC 99788 amphotericin B resistant (IC90>100 µg/ml).(Ref.2)", "Hemolytic Activity": "No hemolysis information or data found in the reference(s) presented in this entry", "Cytotoxicity": "No cytotoxicity information found in the reference(s) presented", "Binding Target": "Not found", "Linear/Cyclic": "Cyclic", "N-terminal Modification": "Free", "C-terminal Modification": "Free", "Stereochemistry": "L", "Structure Description": "Compared to HNP-2, HNP-1 contains one additional residue (Ala) at the N-terminus. It contains a long stretch of a double-stranded antiparallel beta-sheet in a hairpin conformation that contains a beta-bulge, a short region of triple-stranded beta-sheet, and several tight turns.", "Formula": "C157H261N49O43S6", "Mass": 3715.44, "PI": 8.98, "Net Charge": 4, "Hydrophobicity": 0.66, "Half Life": "Mammalian:100 hourYeast:>20 hourE.coli:>10 hour", "Function": "Has antimicrobial activity against Gram-negative bacteria, and to a lesser extent also against Gram-positive bacteria and fungi. Protects blood cells against infection with HIV-1 (in vitro). In comparison with HNP1-3, inhibition of both strains of HIV-1 by HNP4 was noticeably stronger as evidenced by lower IC50 values (2-5 µM) and steeper and more complete inhibition curves.", "PTM": "Contains three disulfide bonds 2-30; 4-19; 9-29.", "Literature": [{"Title": "Human Defensins Inhibit SARS-CoV-2 Infection by Blocking Viral Entry.", "Pubmed ID": "34206990", "Reference": "Viruses. 2021 Jun 26;13(7)1246.", "Author": "Xu C, Wang A, Marin M, Honnen W, Ramasamy S, Porter E, Subbian S, Pinter A, Melikyan GB, Lu W, Chang TL.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=34206990"}, {"Title": "Crystal structures of human alpha-defensins HNP4, HD5, and HD6.", "Pubmed ID": "17088326", "Reference": "Protein Sci. 2006 Dec;15(12)2749-2760.", "Author": "Szyk A, Wu Z, Tucker K, Yang D, Lu W, Lubkowski J.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=17088326"}, {"Title": "Human neutrophil alpha-defensin 4 inhibits HIV-1 infection in vitro.", "Pubmed ID": "15620707", "Reference": "FEBS Lett. 2005 Jan 3;579(1)162-166.", "Author": "Wu Z, Cocchi F, Gentles D, Ericksen B, Lubkowski J, Devico A, Lehrer RI, Lu W.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=15620707"}, {"Title": "Antibacterial activity and specificity of the six human {alpha}-defensins.", "Pubmed ID": "15616305", "Reference": "Antimicrob Agents Chemother. 2005 Jan;49(1)269-275.", "Author": "Ericksen B, Wu Z, Lu W, Lehrer RI.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=15616305"}, {"Title": "The gene encoding the human corticostatin HP-4 precursor contains a recent 86-base duplication and is located on chromosome 8.", "Pubmed ID": "", "Author": "Solomon S.,Sadro L.C.,Palfree R.G.E."}, {"Title": "Structure of a novel human granulocyte peptide with anti-ACTH activity.", "Pubmed ID": "", "Author": "Esch F.,Shimasaki S.,Zhu Q.,Bateman A.,Singh A."}, {"Title": "Purification and characterization of human neutrophil peptide 4, a novel member of the defensin family.", "Pubmed ID": "", "Author": "Scott R.W.,Snable J.L.,Marra M.N.,Griffith J.E.,Wilde C.G."}, {"Title": "Antibiotic proteins of human polymorphonuclear leukocytes.", "Pubmed ID": "", "Author": "Wilde C.,Griffith J.,Campanelli D.,Scott R.W.,Gabay J.E."}, {"Title": "Antibacterial activity and specificity of the six human alpha-defensins.", "Pubmed ID": "R2005J0141", "Author": "Lehrer R.I.,Lu W.,Wu Z.,Ericksen B."}, {"Title": "The consensus coding sequences of human breast and colorectal cancers.", "Pubmed ID": "R2006J1378", "Author": "Lin J.,Parsons D.W.,Wood L.D.,Jones S.,Sjoeblom T."}], "Frequent Amino Acids": "CRV", "Absent Amino Acids": "ADHKMOPQUW", "Basic Residues": 5, "Acidic Residues": 1, "Hydrophobic Residues": 12, "Polar Residues": 23, "Positive Residues": 5, "Negative Residues": 1, "Similar Sequences": [{"SPADE_ID": "SPADE_N_02298", "Similarity": 1.0, "Sequence": "VCSCRLVFCRRTELRVGNCLIGGVSFTYCCTRVD"}, {"SPADE_ID": "SPADE_N_04785", "Similarity": 1.0, "Sequence": "MRIIALLAAILLVALQVRAGPLQARGDEAPGQEQRGPEDQDISISFAWDKSSALQVSGSTRGMVCSCRLVFCRRTELRVGNCLIGGVSFTYCCTRVD"}, {"SPADE_ID": "SPADE_UN_12450", "Similarity": 1.0, "Sequence": "VCSCRLVFCRR"}]}}}